TXT
63
-5
ED
42
-3
CNP
55
-2
CAH
56
-2
DRI
56
-2
RL
75
-4
ETN
61
-3
SLB
42
-4
DG
72
2
PGR
55
-3
EOG
32
-14
ICE
60
-4
SPG
55
-3
MRK
56
-4
RSG
50
-4
FCX
72
-2
PSA
46
-5
ZTS
19
2
MDLZ
22
-2
BAC
75
-3
TXT
63
-5
ED
42
-3
CNP
55
-2
CAH
56
-2
DRI
56
-2
RL
75
-4
ETN
61
-3
SLB
42
-4
DG
72
2
PGR
55
-3
EOG
32
-14
ICE
60
-4
SPG
55
-3
MRK
56
-4
RSG
50
-4
FCX
72
-2
PSA
46
-5
ZTS
19
2
MDLZ
22
-2
BAC
75
-3
Financhill
Back

First Trust NASDAQ Technology Dividend Index Fund Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
32

TDIV
First Trust NASDAQ Technology Dividend Index Fund

Last Price:
$96.65
Seasonality Move:
1.23%
Sell
36

MNPR
Monopar Therapeutics, Inc.

Last Price:
$73.35
Seasonality Move:
36.18%
Sell
32
First Trust NASDAQ Technology Dividend Index Fund (TDIV) is a Sell

Is First Trust NASDAQ Technology Dividend Index Fund a Buy, Sell or Hold?

  • The current First Trust NASDAQ Technology Dividend Index Fund [TDIV] share price is $96.69. The Score for TDIV is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • TDIV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $71.47. The Score for MNPR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TDIV Stock Price Chart

What is First Trust NASDAQ Technology Dividend Index Fund's stock price today?

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $71.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.

TDIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 44.67 Sell
Chaikin Money Flow: 28179 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (94.54 - 99.72) Sell
Bollinger Bands (100): (92.64 - 100.06) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.27 Sell
Relative Strength Index (14 RSI): 37.77 Sell
Chaikin Money Flow: -61015 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (75.54 - 86.44) Sell
Bollinger Bands (100): (44.45 - 88.87) Buy

TDIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 99.46 Sell
20-day SMA: 97.27 Sell
50-day SMA: 98.43 Sell
200-day SMA: 88.31 Buy
8-day EMA: 98.39 Sell
20-day EMA: 98.17 Sell
50-day EMA: 95.95 Buy
200-day EMA: 60.62 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 76.09 Sell
20-day SMA: 80.86 Sell
50-day SMA: 83.38 Sell
200-day SMA: 51.78 Buy
8-day EMA: 75.84 Sell
20-day EMA: 78.85 Sell
50-day EMA: 77.98 Sell
200-day EMA: 56.35 Buy

First Trust NASDAQ Technology Dividend Index Fund Earnings Growth & TDIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

First Trust NASDAQ Technology Dividend Index Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):